Published in Anal Biochem on July 01, 1988
Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc Natl Acad Sci U S A (1998) 7.78
Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. Cancer Res (1995) 6.21
Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett (1990) 5.14
"SMART" drug delivery systems: double-targeted pH-responsive pharmaceutical nanocarriers. Bioconjug Chem (2006) 2.58
Activity of amphipathic poly(ethylene glycol) 5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target. Biochim Biophys Acta (1991) 2.01
Augmentation of transvascular transport of macromolecules and nanoparticles in tumors using vascular endothelial growth factor. Cancer Res (1999) 2.00
Vascular permeability in a human tumour xenograft: molecular charge dependence. Br J Cancer (2000) 1.60
Gamma imaging with negatively charge-modified monoclonal antibody: modification with synthetic polymers. J Nucl Med (1991) 1.45
Accumulation of protein-loaded long-circulating micelles and liposomes in subcutaneous Lewis lung carcinoma in mice. Pharm Res (1998) 1.44
Morphological alterations in endothelial cells from human aorta and umbilical vein induced by forskolin and phorbol 12-myristate 13-acetate: a synergistic action of adenylate cyclase and protein kinase C activators. Proc Natl Acad Sci U S A (1986) 1.17
Influence of the steric barrier activity of amphipathic poly(ethyleneglycol) and ganglioside GM1 on the circulation time of liposomes and on the target binding of immunoliposomes in vivo. FEBS Lett (1991) 1.10
Retrospective reconstruction of individual and collective external gamma doses of population evacuated after the Chernobyl accident. Health Phys (1994) 1.09
A novel class of antitumor antibodies: nucleosome-restricted antinuclear autoantibodies (ANA) from healthy aged nonautoimmune mice. Oncol Res (1997) 1.06
Primary culture of endothelial cells from atherosclerotic human aorta. Part 1. Identification, morphological and ultrastructural characteristics of two endothelial cell subpopulations. Atherosclerosis (1986) 1.04
The fusion of artificial lipid membranes induced by the synthetic arenavirus 'fusion peptide'. Biochim Biophys Acta (1992) 1.02
Liposomes as targetable drug carriers. Crit Rev Ther Drug Carrier Syst (1985) 1.01
Nucleosome-releasing treatment makes surviving tumor cells better targets for nucleosome-specific anticancer antibodies. Cancer Detect Prev (1998) 1.01
Cell proliferation in normal and atherosclerotic human aorta. I. Flow cytofluorometric determination of cellular deoxyribonucleic acid content. Lab Invest (1983) 1.00
Drug delivery to damaged brain. Brain Res Brain Res Rev (2001) 0.98
Controlled delivery of Gd-containing liposomes to lymph nodes: surface modification may enhance MRI contrast properties. Magn Reson Imaging (1995) 0.98
Interaction of Triton X-100 and octyl glucoside with liposomal membranes at sublytic and lytic concentrations. Spectroscopic studies. Biochim Biophys Acta (1990) 0.98
Plug and seal: prevention of hypoxic cardiocyte death by sealing membrane lesions with antimyosin-liposomes. Nat Med (1995) 0.97
Mixed micelles made of poly(ethylene glycol)-phosphatidylethanolamine conjugate and d-alpha-tocopheryl polyethylene glycol 1000 succinate as pharmaceutical nanocarriers for camptothecin. Int J Pharm (2005) 0.96
Heterogeneity of endothelium in human aorta. A quantitative analysis by scanning electron microscopy. Atherosclerosis (1984) 0.96
Endothelial cell culture on fibrillar collagen: model to study platelet adhesion and liposome targeting to intercellular collagen matrix. Proc Natl Acad Sci U S A (1981) 0.96
Gene delivery into ischemic myocardium by double-targeted lipoplexes with anti-myosin antibody and TAT peptide. Gene Ther (2008) 0.92
Blood clearance of radiolabeled antibody: enhancement by lactosamination and treatment with biotin-avidin or anti-mouse IgG antibodies. J Nucl Med (1988) 0.92
[Isolation of highly purified phosphoglycerate kinase from rabbit skeletal muscles]. Biokhimiia (1967) 0.92
PEG-PE/phosphatidylcholine mixed immunomicelles specifically deliver encapsulated taxol to tumor cells of different origin and promote their efficient killing. J Drug Target (2003) 0.92
Toxicity and immunogenicity of Neisseria meningitidis lipopolysaccharide incorporated into liposomes. Infect Immun (1992) 0.91
Preservation of antimyosin antibody activity after covalent coupling to liposomes. Biochem Biophys Res Commun (1979) 0.91
Liposomal diamidine (imidocarb): preparation and animal studies. J Microencapsul (1995) 0.90
Cell proliferation in normal and atherosclerotic human aorta. II. Autoradiographic observation on deoxyribonucleic acid synthesis in primary cell culture. Lab Invest (1983) 0.90
Encapsulation of ATP into liposomes by different methods: optimization of the procedure. J Microencapsul (2004) 0.89
Characterization of in vivo immunoliposome targeting to pulmonary endothelium. J Pharm Sci (1990) 0.89
Cationic bolasomes with delocalized charge centers as mitochondria-specific DNA delivery systems. Adv Drug Deliv Rev (2001) 0.89
DQAsome/DNA complexes release DNA upon contact with isolated mouse liver mitochondria. J Control Release (2001) 0.88
Poly(Hpma)-coated liposomes demonstrate prolonged circulation in mice. J Liposome Res (2001) 0.88
Catecholamine-mediated injury to endothelium in rabbit perfused aorta: a quantitative analysis by scanning electron microscopy. Cor Vasa (1985) 0.87
1H NMR detection of mobile lipids as a marker for apoptosis: the case of anticancer drug-loaded liposomes and polymeric micelles. Mol Pharm (2009) 0.86
Carrier-directed targeting of liposomes and erythrocytes to denuded areas of vessel wall. Proc Natl Acad Sci U S A (1986) 0.86
Analysis of the effectiveness of emergency countermeasures in the 30-km zone during the early phase of the Chernobyl accident. Health Phys (1994) 0.86
Evaluation of quantitative parameters of the interaction of antibody-bearing liposomes with target antigens. Anal Biochem (1985) 0.85
Dibutyryl cyclic AMP decreases proliferative activity and the cholesteryl ester content in cultured cells of atherosclerotic human aorta. Biochem Biophys Res Commun (1982) 0.85
Isolated cells in suspension for biological research--Part III. Structure and functional properties of enterocytes and adipocytes. Exp Pathol (1988) 0.85
Flow cytofluorometric study of lipoprotein interactions with cultured endothelial cells. Cytometry (1982) 0.84
Study of low density lipoprotein interaction with platelets by flow cytofluorimetry. FEBS Lett (1982) 0.84
High-affinity association and degradation of 125I-labelled low density lipoproteins by human hepatocytes in primary culture. FEBS Lett (1985) 0.84
ATP-loaded liposomes effectively protect mechanical functions of the myocardium from global ischemia in an isolated rat heart model. J Control Release (2005) 0.84
The principles of enzyme stabilization. IV. Modification of 'key' functional groups in the tertiary structure of proteins. Biochim Biophys Acta (1979) 0.84
Characterization of an antiglycoprotein Ib monoclonal antibody that specifically inhibits platelet-thrombin interaction. Thromb Res (1991) 0.84
Enzyme immunoassay of the receptors for modified low density lipoprotein. Anal Biochem (1986) 0.84
Intimal cells and atherosclerosis. Relationship between the number of intimal cells and major manifestations of atherosclerosis in the human aorta. Am J Pathol (1986) 0.84
Effect of metabolic inhibitors on platelet attachment, spreading and aggregation on collagen-coated surfaces. Thromb Res (1987) 0.83
Aortic endothelium of alloxan diabetic rabbits: a quantitative study using scanning electron microscopy. Diabetologia (1982) 0.83
Block-copolymer of polyethylene glycol and polylysine as a carrier of organic iodine: design of long-circulating particulate contrast medium for X-ray computed tomography. J Drug Target (1997) 0.83
Inhibition of cholesterol synthesis by lovastatin tested on six human cell types in vitro. Lipids (1990) 0.83
VLDL apoprotein secretion and apo-B mRNA level in primary culture of cholesterol-loaded rabbit hepatocytes. FEBS Lett (1988) 0.82
Estimation of 131I thyroid doses for the evacuees from Pripjat. Radiat Environ Biophys (1996) 0.82
Comparison of different lasers in terms of thrombogenicity of the laser-treated vascular wall. Lasers Surg Med (1988) 0.82
A 90-kd surface antigen from a subpopulation of smooth muscle cells from human atherosclerotic lesions. Am J Pathol (1989) 0.82
Identification of intimal subendothelial cells from human aorta in primary culture. Atherosclerosis (1988) 0.82
Protein immobilization on the surface of liposomes via carbodiimide activation in the presence of N-hydroxysulfosuccinimide. FEBS Lett (1988) 0.81
Biodistribution of anti-CEA F(ab')2 fragments conjugated with chelating polymers: influence of conjugate electron charge on tumor uptake and blood clearance. Nucl Med Biol (1993) 0.81
A new hydrophobic anchor for the attachment of proteins to liposomal membranes. FEBS Lett (1986) 0.81
Effect of cell cholesterol content on apolipoprotein B secretion and LDL receptor activity in the human hepatoma cell line, HepG2. Biochim Biophys Acta (1989) 0.81
Both apolipoproteins B-48 and B-100 are synthesized and secreted by the human intestine. J Lipid Res (1990) 0.81
Hypoxia-targeted siRNA delivery. Angew Chem Int Ed Engl (2014) 0.81
Human plasma fibronectin promotes the adhesion and spreading of platelets on surfaces coated with fibrillar collagen. FEBS Lett (1981) 0.80
FITC-labeled lipopolysaccharide: use as a probe for liposomal membrane incorporation studies. FEBS Lett (1990) 0.80
Inhibition of cholesterol synthesis and esterification regulates high density lipoprotein interaction with isolated epithelial cells of human small intestine. J Lipid Res (1990) 0.80
Incorporation of hydrophilic protein modified with hydrophobic agent into liposome membrane. Biochim Biophys Acta (1980) 0.80
Enzyme-linked immunoreceptor assay of low-density-lipoprotein receptors. Anal Biochem (1985) 0.80
Mitochondriotropic cationic vesicles: a strategy towards mitochondrial gene therapy. Curr Pharm Biotechnol (2000) 0.80
Massage-induced release of subcutaneously injected liposome-encapsulated drugs to the blood. J Control Release (1998) 0.80
Binding of partially reassembled high-density lipoprotein to isolated human small intestine epithelial cells. Effect of lipid composition. Biochim Biophys Acta (1988) 0.79
Cholesterol can stimulate secretion of apolipoprotein B by cultured human hepatocytes. Biochim Biophys Acta (1985) 0.79
Adult human aortic cells in primary culture: heterogeneity in shape. Heart Vessels (1986) 0.79
Interconversions of HDL subfractions in normolipidemic and hypoalphacholesterolemic sera incubated with fibroblasts and hepatoma cell line Hep-G2. Biochem Int (1988) 0.79
Radioimmunoimaging of lung vessels: an approach using indium-111-labeled monoclonal antibody to angiotensin-converting enzyme. J Nucl Med (1989) 0.79
Comparative studies on covalent and noncovalent immobilization of protein molecules on the surface of liposomes. Biochem Biophys Res Commun (1978) 0.79
[Distribution of myosin in a primary culture of human aortic intimal cells]. Biull Eksp Biol Med (1984) 0.79
Negatively charged polymers protect antinuclear antibody against inactivation by acylating agents. Anal Biochem (2001) 0.79
Selective DNA release from DQAsome/DNA complexes at mitochondria-like membranes. Drug Deliv (2000) 0.79
Cationic liposomes enhance targeted delivery and expression of exogenous DNA mediated by N-terminal modified poly(L-lysine)-antibody conjugate in mouse lung endothelial cells. Biochim Biophys Acta (1992) 0.79
An extract of feverfew inhibits interactions of human platelets with collagen substrates. Thromb Res (1987) 0.79
Immobilization of enzymes on slowly soluble carriers. J Biomed Mater Res (1977) 0.79
Towards mitochondrial gene therapy: DQAsomes as a strategy. J Drug Target (2001) 0.79
Succinylated polylysine as a possible link between an antibody molecule and deferoxamine. Bioconjug Chem (1991) 0.78
Effect of bezafibrate on lipoprotein secretion by cultured human hepatocytes. Atherosclerosis (1987) 0.78
Artificial HDL as an anti-atherosclerotic drug. Lancet (1984) 0.78
Step-by-step analysis of adhesion of human platelets to a collagen-coated surface defect in initial attachment and spreading of platelets in von Willebrand's disease. Thromb Res (1984) 0.78
Binding of antibodies in liposomes to extracellular matrix antigens. J Cell Biochem (1985) 0.78